Treatment Update
Dedicated to updates about treatments for AD/HD
November 12, 2009
FDA Approves New Shire Medication for AD/HD
The FDA has approved INTUNIV, a nonstimulant
medication produced by Shire Pharmaceuticals. For more information
about this product, please visit the FDA Center for Drug Evaluation and Research and
type “INTUNIV” in the search field. CHADD’s
CDC-funded National
Resource Center on AD/HD also provides information on treatment
options for AD/HD. CHADD encourages parents of children with the
disorder and adults with the disorder to consult their treatment
professional before making any decisions about treatment.
| 
